Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05775510 · ClinicalTrials.gov registry record
Study to Evaluate Neuromodulation Subject Experience With Contemporary Spinal Cord Stimulation (SCS) Modalities for Chronic Pain
A clinical trial, sponsored by MedtronicNeuro.
- Terminated
- Registry status
- 91
- Enrollment target
NCT05775510 is a clinical trial that was terminated before completion, run by MedtronicNeuro. The registered enrollment target is 91 participants.
The verdict
NCT05775510 was terminated before completion, sponsored by MedtronicNeuro.
- TERMINATED
- Registry status
- 91 participants
- Enrollment target
Study Summary
Medtronic, Inc. is sponsoring the SENSE SCS clinical study, a prospective, multi-center, post-market, non-randomized, observational study with a hybrid decentralized model of execution, utilizing a mobile application for the collection of patient reported outcomes (PROs). The purpose of the study is to evaluate workflow of a mobile application for collection of PROs and to gather data on patient experience with spinal cord stimulation therapy.
Interventions
- DEVICE Commercially available neurostimulation systems
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2023-04-25 |
| Est. Completion | 2025-05-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05775510
The ClinicalTrials.gov registry entry for NCT05775510 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Commercially available neurostimulation systems is the first listed.
NCT05775510 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05775510 about?
NCT05775510 is a clinical study titled "Study to Evaluate Neuromodulation Subject Experience With Contemporary Spinal Cord Stimulation (SCS) Modalities for Chronic Pain". Medtronic, Inc. is sponsoring the SENSE SCS clinical study, a prospective, multi-center, post-market, non-randomized, observational study with a hybrid decentralized model of execution, utilizing a mobile application for the collection of patient reported outcomes (PROs). The purpose of the study is...
What is the current status of trial NCT05775510?
This trial is currently terminated. The enrollment target is 91 participants. The study started on 2023-04-25. Estimated completion is 2025-05-29.
What interventions are being tested in trial NCT05775510?
The interventions under investigation include: Commercially available neurostimulation systems (DEVICE).
Who is sponsoring clinical trial NCT05775510?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.